The Latest On Aubrey McClendon

The death of Aubrey McClendon, the former CEO of Chesapeake Energy Corporation (NYSE: CHK), was an accident, clearing the air on suicide rumors.

Wall Street Journal, citing the autopsy report, said the Oklahoma medical examiner ruled the crash that killed McClendon was an accident.

Though no alcohol was involved in the accident, an unspecified amount of over-the-counter drug doxylamine (which can be used as an antihistamine or to treat insomnia) was found in McClendon's system, the report said.

According to WSJ, "McClendon suffered a number of injuries in the single-vehicle crash, including several broken ribs, a broken pelvis and a broken back, as well as lacerations to several internal organs."

Related Link: Is Dennis Gartman The Best Contrarian Indicator For Oil Prices?

These findings were in line with the medical examiner's previous determination that the former chief executive of Chesapeake died of multiple blunt force trauma.

WSJ said the autopsy report shows that while McClendon's heart was damaged by the crash, he didn't appear to suffer a heart-related medical event.

McClendon met with the deadly accident on March 2, one day after he was indicted on a single count of conspiring to rig the price of oil and gas leases. The U.S. Justice Department dropped that charge in the wake of McClendon's death.

The timing of the accident triggered suicide rumors.